DarioHealth Corp. DRIO

6.63 (0.14) (2.07%) as of 25 Sep
Market cap
$66.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.03 1.43 2.36 3.72 10.49 11.25 1.97 0.12 0.15 0.29
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(7.70) (5.73) (6.53) (12.95) (14.22) (12.61) (5.21) (0.26) (0.32) (0.44)
P/B ratio
0.67 0.54 0.82 1.29 2.52 3.03 0.79 0.10 0.20 0.00
Price to Tangible BV
0.00 0.00 4.32 3.61 6.84 3.03 0.79 0.10 0.20 0.00
EV/Sales
2.69 1.44 1.94 2.90 8.75 7.52 (0.65) (1.39) (0.62) (0.18)
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.59 0.23 0.05
EV/Operating CF
(2.32) (1.01) (1.30) (1.68) (3.56) (3.21) 0.31 0.90 0.30 0.06
EV/FCF
(2.27) (0.99) (1.26) (1.65) (3.54) (3.19) 0.31 0.89 0.29 0.05
Quick Ratio
3.30 2.15 3.38 2.98 2.74 4.53 4.12 2.27 1.61 0.70
Current Ratio
3.76 2.44 3.79 3.39 3.17 4.85 4.39 2.54 2.01 1.00
Net Debt/EBITDA
(0.13) (0.01) 0.17 0.43 0.50 0.96 1.13 0.64 0.28 0.12
Debt/Assets
27.93% 24.33% 29.61% 22.59% 0.28% 1.50% 3.14% 0.00% 0.00% 0.00%
Debt/Equity
0.45 0.40 0.49 0.34 0.00 0.02 0.04 0.00 0.00 0.00
Asset Turnover
0.20 0.25 0.19 0.25 0.30 0.25 0.39 0.70 0.95 0.63
Operating CF/Net income
0.42 0.94 0.48 0.75 0.64 0.54 0.75 0.63 0.66 0.72
Capex/Depreciation
(0.05) (0.02) (0.12) (0.12) (0.06) (0.26) (0.54) (0.34) (1.00) (2.09)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(88.23%) (62.97%) (91.95%) (77.12%) (138.55%) (140.73%) (150.19%) (284.41%) 1,230.62% 285.85%
ROA
(53.93%) (38.07%) (58.92%) (58.04%) (115.68%) (110.39%) (108.08%) (173.87%) (295.47%) (259.40%)
ROIC
(31.63%) (49.91%) (70.80%) (61.85%) (95.93%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(234.80%) (166.57%) (177.72%) (135.93%) (246.68%) (119.63%) (113.74%) (211.00%) (410.21%) (1,272.70%)
Average Days of Receivables
73.54 96.38 92.88 106.19 60.09 147.33 45.34 27.05 62.55 95.06
Research and Development Expense of Revenue
61.68% 89.42% 99.49% 71.05% 83.94% 58.51% 48.84% 49.72% 63.77% 76.85%
Selling, General and Administrative Expense of Revenue
158.90% 173.20% 206.00% 169.28% 308.28% 369.36% 219.74% 213.38% 240.48% 289.58%
Intangible Assets out of Total Assets
0.67 0.64 0.49 0.43 0.54 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
41.88% 58.42% 96.80% 61.38% 121.73% 146.54% 29.86% 50.82% 73.97% 37.03%
Graham Net Nets
(0.16) (0.16) 0.19 0.26 0.14 0.32 1.16 8.73 3.90 (9.10)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,992.04
Earnings Yield
(91.65%) (112.17%) (120.13%) (60.46%) (32.23%) (40.83%) (122.97%) (2,061.86%) (3,369.22%) (1,251.23%)
Free Cash Flow Yield
(58.34%) (101.34%) (65.33%) (47.32%) (23.55%) (20.95%) (106.44%) (1,268.98%) (1,445.32%) (1,118.18%)
Revenue per Share
5.61 11.03 14.35 23.40 24.73 25.41 66.72 126.18 214.52 215.62
Operating CF per Share
(6.51) (15.73) (21.41) (40.48) (60.76) (59.48) (138.79) (195.73) (440.62) (644.54)
Capex per Share
(0.04) (0.06) (0.41) (0.48) (0.31) (0.40) (0.86) (1.21) (8.09) (62.15)
Free Cash Flow per Share
(6.55) (15.78) (21.83) (40.97) (61.08) (59.87) (139.66) (196.95) (448.71) (706.69)
Cash per Share
6.59 11.68 26.14 41.90 43.39 96.50 181.69 190.73 164.98 101.38
Shareholders Equity per Share
17.05 29.37 40.99 67.69 103.12 94.40 166.76 152.30 163.53 (503.15)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
17.05 29.37 40.99 67.69 103.12 94.40 166.76 152.30 163.53 (503.15)
Free Cash Flow
(26.08) (38.70) (30.96) (48.42) (50.67) (17.85) (15.82) (11.54) (10.81) (9.19)
Working Capital
25.74 23.89 34.84 46.17 31.23 27.09 17.72 7.94 3.03 0.01
Capital Expenditures
(0.14) (0.14) (0.58) (0.57) (0.26) (0.12) (0.10) (0.07) (0.19) (0.81)
Net Current Asset Value
(7.09) (6.34) 9.09 26.33 30.38 26.87 17.26 7.94 3.03 (7.48)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.58 0.22 0.04
Capex to Sales
0.01 0.01 0.03 0.02 0.01 0.02 0.01 0.01 0.04 0.29
Net Profit Margin
(276.11%) (151.56%) (312.06%) (230.82%) (383.98%) (436.95%) (276.37%) (247.44%) (309.44%) (414.09%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
5.72 10.48 5.55 5.99 6.35 0.79 0.28 0.28 0.22 0.43
Cash ROIC
(21.21%) (30.31%) (25.27%) (31.09%) (41.95%) (31.87%) (40.68%) (60.71%) (145.11%) 177.68%
Accounts Receivable Turnover
3.84 4.39 3.08 4.84 6.38 3.79 10.17 10.31 6.40 3.37
Accounts Payable Turnover
3.25 6.60 8.32 4.84 4.36 2.45 2.35 2.54 2.11 2.60
Inventory Turnover
2.14 2.81 2.21 2.54 3.88 2.73 3.56 4.40 3.72 4.88
Average Days of Payables
110.25 80.70 28.73 47.08 112.68 178.79 121.81 166.91 175.17 182.05
Days of Inventory on Hand
162.51 125.96 128.59 161.32 137.35 165.31 104.01 89.29 111.99 89.22
Average Receivables
5.82 6.16 6.61 5.71 3.22 2.00 0.74 0.72 0.81 0.83
Average Payables
2.99 2.09 1.73 3.72 3.79 2.07 2.12 2.21 1.83 1.40
Average Inventory
4.53 4.91 6.51 7.09 4.26 1.85 1.40 1.28 1.04 0.74
Average Assets
114.48 107.64 107.79 109.98 68.09 29.99 19.33 10.52 5.41 4.47
Average Common Equity
69.97 65.08 69.07 82.77 56.85 23.52 13.91 6.43 (1.30) (4.06)

Fold the line items

Columns are period end dates